Teva Pharmaceutical (TEVA) Declares $0.32 Quarterly Dividend; 3.4% Yield

Go back to Teva Pharmaceutical (TEVA) Declares $0.32 Quarterly Dividend; 3.4% Yield

Teva Pharmaceutical (TEVA) Tops Q1 EPS by 2c

May 2, 2013 7:02 AM EDT

Teva Pharmaceutical (NYSE: TEVA) reported Q1 EPS of $1.12, $0.02 better than the analyst estimate of $1.10. Revenue for the quarter came in at $4.9 billion versus the consensus estimate of $4.85 billion.

For earnings history and earnings-related data on Teva Pharmaceutical (TEVA) click here.... More